European Pharmaceutical Review

DECEMBER 22, 2023

KarXT targets both the M1 and M4 muscarinic receptors, resulting in a differentiated safety and efficacy profile. It has demonstrated improvements in cognition and is not associated with common side effects of currently approved treatments like weight gain.

Food and Drug Administration 92

Food and Drug Administration Side effects Safety Food 92

European Pharmaceutical Review

NOVEMBER 2, 2023

The FDA said its approval of Wezlana is based on “a comprehensive review of scientific evidence demonstrating it is highly similar to Stelara and that there are no clinically meaningful differences between the two products in terms of safety, purity and potency.” Like Stelara, the most serious known side effect of Wezlana is infection.

Food and Drug Administration 85

Food and Drug Administration FDA Side effects Safety 85

Clarivate

MAY 1, 2024

Are the powerful weight loss and diabetes treatments a lose-lose for medical technology companies? GLP-1 drugs like semaglutide (Ozempic®/Wegovy®) and tirzepatide (Mounjaro®/Zepbound®) spooked investors who feared that these treatments could disrupt a number of medical technologies, including surgical obesity interventions and orthopedics.

Side effects 59

Side effects Physicians Medical Patients 59

Contrarian Sales Techniques

FEBRUARY 25, 2023

A point of view from a Medical Sales Rep I strongly believe that the most effective insurance policy is not to get sick. But it is crucial to remember that not all illnesses are preventable, and some may require medical treatment, such as accidents or injuries. This is before a drug can be approved for public use.

Side effects 52

Side effects Medical sales reps Insurance Pharmacology 52

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. New hope for stomach cancer patients.

Patients 81

Patients Food and Drug Administration Side effects Safety 81

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions.

Healthcare 79

Healthcare Healthcare Electronics Safety 79

PM360

MAY 25, 2023

Carl Marci, Chief Psychiatrist and Managing Director of Mental Health and Neuroscience at OM1 , about how the company is using its Mental Health and Neuroscience Real-World Data Network to help improve personalized treatment for mental health patients and increase awareness about issues related to mental health disorders.

Side effects 95

Side effects Medical Patients Networking 95

European Pharmaceutical Review

OCTOBER 18, 2022

Kite announced that the European Commission (EC) has approved the use of cell therapy Yescarta ® for treatment of patients with diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL), who relapse within 12 months or are refractory to, first-line chemoimmunotherapy. In the SOC arm, 83 percent of patients had Grade ?3

Side effects 98

Side effects Safety Patients Medical 98

pharmaphorum

JULY 1, 2022

billion buyout of Principia Biopharma has run into trouble, after the FDA placed it on partial clinical hold while a safety signal is investigated. Those changes haven’t been enough to prevent the FDA from taking action, although outside the US the studies will continue as planned with the tighter safety monitoring.

Side effects 85

Side effects Safety Biopharma Recruitment 85

European Pharmaceutical Review

DECEMBER 14, 2023

Over the past few years, we have researched the types of evidence used in regulatory decisions for drug product withdrawals due to safety concerns in Europe. But from a safety point of view, observational studies can be more representative of the population the drug will serve. As of October 2023, 62.93

Safety 110

Safety Medicine Competition Networking 110

pharmaphorum

JANUARY 3, 2023

The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an add-on to their current therapy for more than six months. in the evenamide group.

Side effects 103

Side effects Biopharma Patients Competition 103

pharmaphorum

AUGUST 11, 2022

In 2016, the estimated annual cost of drug-related morbidity and mortality resulting from non-optimised medication therapy was $528.4 Pharmacogenomics, the understanding of how genes impact an individual’s response to medications, provides a potential outlet to better optimised therapies. billion in the United States alone.

Side effects 89

Side effects Medical Prescription Patients 89

Legacy MEDSearch

DECEMBER 12, 2022

Dr. Synowiec is the medical lead of this Coverage with Evidence program. “Nerivio is an excellent treatment option for our patients with migraine, especially those who do not respond to medications, or cannot tolerate their side effects. Often, treating this prevalent disease may require combination therapy.

Side effects 98

Side effects Insurance FDA Pharmacology 98

World of DTC Marketing

DECEMBER 23, 2020

DTC marketers who believe that DTC is essentially the same as before the pandemic are failing to recognize significant shifts in patient behavior regarding prescription drugs. Any discussion around DTC should acknowledge the following: 1ne: DTC is more effective for some health categories than others. What are the side effects?

Prescription 249

Prescription Doctors Side effects Marketing 249

Legacy MEDSearch

JUNE 28, 2023

2 The incidence of infantile hemangiomas (IHs) in neonatal patients (under 28 days of age) varies, with a reported rate ranging from 1.1 2 The incidence of infantile hemangiomas (IHs) in neonatal patients (under 28 days of age) varies, with a reported rate ranging from 1.1 ”, states board-certified cosmetic dermatologist, Roy G.

Medical 52

Medical FDA Recruitment Side effects 52

Pharmaceutical Technology

JANUARY 27, 2023

However, Briumvi is unlikely to appeal to patients who are already receiving Genentech’s Ocrevus or Novartis’s Kesimpta. As for Briumvi’s side effects, around 45% of patients experienced infections of the upper respiratory tract, which was 4% higher in comparison to Aubagio. All three treatments are monoclonal antibodies.

Marketing 52

Marketing Side effects Safety Specialization 52

Pharmaceutical Technology

NOVEMBER 14, 2022

In September, a group from Friedrich Alexander University Erlangen-Nuremberg reported that five patients with lupus achieved remission after an infusion of autologous chimeric antigen receptor (CAR)-T cells led to a deep depletion of B cells. All five patients achieved remission after three months.

Side effects 144

Side effects Patients Manufacturing Safety 144

Contrarian Sales Techniques

MAY 17, 2024

We were drilled on the science behind our medications, their benefits, potential side effects, and the competitive landscape. Working for an ethical pharmaceutical company, we were trained to prioritize safety, efficacy, and quality above all else. Back then, training was heavily focused on product knowledge.

Training 52

Training Pharmaceutical Ethics Healthcare Provider 52

European Pharmaceutical Review

APRIL 20, 2023

“These results are exciting… this treatment led to fewer days with migraine for people who had already tried up to four other types of drugs to prevent migraine and either had no improvement or had side effects that outweighed any benefits,” commented study author Dr Patricia Pozo-Rosich, PhD at Vall d’Hebron University Hospital in Barcelona, Spain.

Side effects 83

Side effects Safety Medical Pharmaceutical 83

European Pharmaceutical Review

FEBRUARY 9, 2023

If progress continues in a Phase III clinical trial, this medication would be the first FDA-approved drug specifically for people with notalgia paresthetica. If progress continues in a Phase III clinical trial, this medication would be the first FDA-approved drug specifically for people with notalgia paresthetica.

Food and Drug Administration 75

Food and Drug Administration FDA Side effects Medicine 75

pharmaphorum

SEPTEMBER 16, 2022

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, side effects do happen.

Management 77

Management Side effects Patients Safety 77

Celeritas

SEPTEMBER 26, 2022

QR codes were initially reserved for marketing and sales-related functions, but recently they have made quite some headway in the medical field. A) Aiding Healthcare Professionals (HCPs): Storage of Patient Information: The common method of use of QR codes is in the organization and accessibility of patient records.

Physicians 52

Physicians Patients Medical Management 52

World of DTC Marketing

FEBRUARY 9, 2021

Consistently we heard that they like images of real patients or a REAL doctor with one key message communicated. The message should not be “medical terminology” but, instead, put into the medication’s real-world benefit. 6ix: Safety information needs context. 6ix: Safety information needs context.

Pharma 180

Pharma Side effects Medical FDA 180

World of DTC Marketing

APRIL 15, 2021

These groups are also latching onto reports of real deaths following the shot, blaming the vaccine and disregarding medical information that other causes are to blame. While patients have the right to full disclosure, misinformation and scare tactics could lead to more deaths from COVID. A new approach to market was needed.

Food and Drug Administration 203

Food and Drug Administration Government Safety Manufacturing 203

Pharmaceutical Technology

JUNE 15, 2023

The need for new medical treatments and drugs has never been greater. But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Pharma companies need tools like AI that can reliably improve this percentage without jeopardizing safety.

Food and Drug Administration 52

Food and Drug Administration Side effects Recruitment Safety 52

pharmaphorum

JULY 19, 2022

Incyte’s Opzelura cream has become the first medical treatment approved to re-pigment the skin of people with vitiligo in the US, adding to its current use in atopic dermatitis. The company is gunning for sales in atopic dermatitis alone of $1.5 The post FDA clears Incyte’s Opzelura as first vitiligo therapy appeared first on.

FDA 95

FDA Side effects Sales Safety 95

European Pharmaceutical Review

JULY 20, 2022

Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. Supporting regulators. It focused on data from France, Germany and the UK.

Medicine 76

Medicine Safety Side effects Electronics 76

European Pharmaceutical Review

OCTOBER 12, 2022

A Phase III trial evaluating TauRx Therapeutics’ oral drug hydromethylthionine mesylate (HMTM), a tau aggression inhibitor, showed the medication continued to improve cognition over a pre-treatment baseline in patients with early Alzheimer’s for the first time. The safety data from the trial was consistent with earlier trial data.

Side effects 86

Side effects Safety Patients Sales 86

pharmaphorum

AUGUST 8, 2022

Karuna Therapeutics has unveiled positive topline results from its phase 3 EMERGENT-2 trial evaluating the efficacy, safety, and tolerability of its lead investigational therapy, KarXT (xanomeline-trospium), in adults with schizophrenia.

Side effects 52

Side effects Leads Safety Medical 52

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? Doctors, caregivers, life sciences companies, and even companies in other industries have attempted to answer this question for as long as medications have been available. But it is not a simple answer. from 2021 and reach $4.2 billion in 2025.

Prescription 105

Prescription Medical Side effects Patients 105

PM360

NOVEMBER 29, 2022

Drug labels hold value for life sciences companies because they are rich, extensive documents that can be used across labeling, regulatory, safety, and medical affairs. Understanding patient sub-group exceptions for competitive or for label development purposes. Extracting contra-indications to understand competitive coverage.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

pharmaphorum

JANUARY 3, 2023

” Rawlins was knighted in the 1999 Queen’s New Year Honours for services to the improvement of patient protection from the side effects of medicines, and in 2017 was appointed Knight Grand Cross of the Order of the British Empire (GBE) for services to the safety of medicines, healthcare, and innovation. .”

Side effects 52

Side effects Medicine Safety Healthcare 52

PM360

AUGUST 9, 2022

PM360 asked life sciences industry experts with knowledge about improving adherence to medication to share the latest trends and approaches being used and to tell us how better data and monitoring can help solve this issue. How can the industry better measure adherence to medication and monitor it at both a large and small scale?

Medical 105

Medical Electronics Patients Healthcare 105

Legacy MEDSearch

OCTOBER 25, 2023

Theranica , a neuromodulation therapeutics company, announced the publication of a comprehensive clinical study in Advances in Therapy examining the long-term utilization, clinical efficacy, and safety of Nerivio ® , a Remote Electrical Neuromodulation (REN) device for the treatment of migraine. As for clinical efficacy, 74.1%

Side effects 52

Side effects Recruitment Networking Management 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

Specialization 45

Specialization Leads Pharma Side effects 45

European Pharmaceutical Review

AUGUST 25, 2022

However, patient survival rates remain low, with the standard of care delivering a progression?free Upon diagnosis, initial treatment consists of debulking the tumour via surgical resection; however, the location of the tumour dictates the effectiveness of this tactic. It is also the most common primary brain tumour found in adults.

Side effects 95

Side effects Safety Patients Engineering 95

European Pharmaceutical Review

MARCH 24, 2023

Following the recent announcement of topline results from 89bio’s Phase IIb trial, ENLIVEN, evaluating FGF21 analogue pegozafermin for nonalcoholic steatohepatitis (NASH), a serious liver condition, EPR spoke with Dr Hank Mansbach, the company’s Chief Medical Officer. NASH currently has no approved treatments.

Medical 81

Medical Side effects Safety Pharmaceutical 81